We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CYCC market cap is 2.05M. The company's latest EPS is USD -26.9987 and P/E is -0.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 373k | 16k |
| Operating Income | -6.47M | -8.85M | -7.32M | -5.93M | -6.85M |
| Net Income | -5.15M | -7.47M | -5.85M | -5.5M | -6.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 420k |
| Operating Income | -9.68M | -10.64M | -22.94M | -27.66M | -25.45M |
| Net Income | -8.03M | -12.42M | -19.09M | -21.4M | -22.76M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.02M | 27.5M | 22.06M | 16.44M | 12.5M |
| Total Liabilities | 4.46M | 7.5M | 7.42M | 6.81M | 8.2M |
| Total Equity | 22.07M | 15.51M | 10.15M | 5.14M | 4.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.31M | 36.8M | 42.59M | 27.5M | 8.81M |
| Total Liabilities | 3.61M | 3.54M | 5.32M | 7.5M | 8.2M |
| Total Equity | 11.7M | 33.26M | 37.26M | 15.51M | 607k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.66M | -20.83M | -6.86M | -8.17M | -12.2M |
| Investing | -7k | -7k | -6k | -6k | -6k |
| Financing | 2.96M | 3M | -50k | -101k | -151k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.45M | -7.93M | -18.54M | -20.83M | -16.11M |
| Investing | 28k | -96k | -27k | -7k | -6k |
| Financing | 3.85M | 29.5M | 21.74M | 3M | 848k |
| Market Cap | 2.05M |
| Price to Earnings Ratio | -0.09 |
| Price to Sales Ratio | 4.66 |
| Price to Cash Ratio | 0.58 |
| Price to Book Ratio | 3.22 |
| Dividend Yield | - |
| Shares Outstanding | 842.86k |
| Average Volume (1 week) | 641.1k |
| Average Volume (1 Month) | 2.39M |
| 52 Week Change | -71.48% |
| 52 Week High | 13.20 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 0.03 (1.22%) |
| Company Name | Cyclacel Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cyclacel.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
